Skip to content
Baret News – Lifestyle
Author:
Mineralys Therapeutics, Inc.
Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 27, 2026
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
May 21, 2026
Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 6, 2026
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
May 5, 2026
Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026
April 29, 2026
←
Previous Page
1
2
3